Latest Headlines

  1. Avance Clinical Showcases Early Phase Expertise And The Australian Advantage For EU Biotechs At BIO-Europe Vienna 11/5/2025

    Avance Clinical, the largest premium full-service Australian headquartered CRO with more than 30 years of early phase expertise, is highlighting its Early Phase Center of Excellence for Biotechs and the well-established Australian Advantage to European biotechs ahead of BIO-Europe in Vienna, November 3-5, 2025.

  2. Meet Avance Clinical At SCOPE Summit 2026 In Orlando, Florida 11/5/2025

    Avance Clinical is excited to announce our participation in SCOPE Summit 2026, one of the most influential gatherings in clinical operations, where leading innovators in biotech, pharma, CROs, and technology come together to share strategies shaping the future of global drug development.

  3. Avance Clinical Launches Renal And Cardiometabolic Center Of Excellence To Optimize Patient Recruitment To Elevate Study Success 10/30/2025

    Avance Clinical, a partner for biotechs providing global contract research organization services, has announced the launch of the Renal & Cardiometabolic Center of Excellence.

  4. Tema Sinergie Acquires Majority Stake In Aseptic Filling OEM 6Bio 10/29/2025

    TEMA Sinergie S.p.A., a global leader in isolation systems for the Radiopharma and Biotech Pharma industries, today announced the acquisition of a majority stake in 6Bio, a Spanish company specialized in high-performance aseptic filling technology.

  5. LOTTE BIOLOGICS And SK pharmteco Sign Strategic Partnership To Strengthen Global ADC CDMO Capabilities 10/29/2025

    Through this collaboration, the two companies will jointly investigate providing integrated, one-stop CDMO services to global clients, offering differentiated ADC solutions that span from development to commercial manufacturing.

  6. Avance Clinical Unveils Dedicated CNS Center Of Excellence For Expert Clinical Trial Services In Neuroscience 10/28/2025

    Avance Clinical, the award-winning Australian-led, global CRO built exclusively to service the clinical research needs of biotech companies, today announced the launch of its Center of Excellence dedicated to central nervous system (CNS) disorders.

  7. SK pharmteco Achieves Highest-Level My Green Lab Certifications Across Europe And Asia 10/28/2025

    The certified facilities are Small Molecule Europe (Swords, Ireland) and Small Molecule Asia (Daejeon, South Korea), and the certifications cover the areas of Quality Control, Process Research & Development, and Analytical Research & Development.

  8. AGC Biologics Partners With Rarity PBC To Advance Life-Saving Gene Therapy For 'Bubble Baby Disease' 10/24/2025

    AGC Biologics announced an agreement with Rarity PBC to provide comprehensive development and GMP manufacturing for Rarity's gene therapy, RDP-101, for Adenosine Deaminase Severe Combined Immunodeficiency Disorder.

  9. Aseptic Filling OEM AST To Exhibit At CPHI Frankfurt 2025 10/23/2025

    From R&D and manufacturing to packaging and distribution, CPHI is where groundbreaking ideas meet the partnerships that bring them to life.

  10. SK pharmteco Boosts Domestic Peptide Scale-Up With Investment In California Facility 10/23/2025

    This expansion, combined with SK pharmteco’s industry-leading chromatography expertise and existing development and manufacturing capabilities in the United States, positions the company to meet the rising demand for U.S. peptide development and domestic clinical and commercial manufacturing.